December 03, 2014
Newtopia announced today a $2-million round of financing today from Bloom Burton & Co., an investment banking firm specializing in the health sector. Newtopia has now raised a total of $8 million in venture capital. “We are thrilled with the support from Bloom Burton, an organization with deep expertise in healthcare innovation, development and commercialization,” said Jeff Ruby, Founder & CEO, Newtopia. “Bloom Burton understands the corporate health landscape and the exciting growth opportunities for Newtopia, especially in markets such as the US, where population health trends and new legislation have highlighted the urgent need for corporations to play a supporting role in employee health.”
BlueDot, a data analytics platform that tracks and predicts the global spread of infectious diseases has secured Series A venture capital funding from Horizons Ventures, early investors in Facebook, Skype and Spotify. “We are excited about our partnership with Horizons because of their track record in helping companies amplify the impact of innovative technology,” said Albert Tseng, chief operating officer of BlueDot. “Another fundamental backbone of the partnership is that Horizons shares our vision of using business to address important social challenges in the world; in our case using technology to predict and mitigate against the spread of dangerous infectious diseases.”
MaRS Investment Accelerator Fund, Export Development Canada and Ryerson Futures have contributed $645,000 to the development of Sampler, an online product sampling management and analytics platform. “Sampler’s clients are looking for more targeted and measurable ways to distribute promotional offers online,” said Marie Chevrier, Sampler’s Founder. “This investment will be geared towards growing Sampler’s technology, sales and marketing teams in Toronto, and to open a New York branch in 2015 to support existing customers in the big city.”